BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• BrightSpring Health Services, Inc. has received a consensus recommendation of "Moderate Buy" from eleven brokerages, with an average price objective set at $25.67.
• The company reported a 15.3% year-over-year increase in quarterly revenue, amounting to $3.15 billion, and beat earnings expectations with $0.22 EPS.
• Insider activity included significant share sales, with Phoenix Aggregator L.P. Kkr selling over 13 million shares, representing a 14.29% decrease in their position.

Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $25.6667.

BTSG has been the subject of several research reports. Wells Fargo & Company boosted their price objective on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the company an "overweight" rating in a research report on Tuesday, May 13th. Mizuho set a $26.00 price target on shares of BrightSpring Health Services in a research report on Monday, May 5th. Morgan Stanley upped their price target on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Cowen reaffirmed a "buy" rating on shares of BrightSpring Health Services in a research report on Monday, August 4th. Finally, TD Cowen began coverage on shares of BrightSpring Health Services in a research note on Monday, June 23rd. They set a "buy" rating and a $37.00 price objective for the company.

BrightSpring Health Services Price Performance

BrightSpring Health Services stock opened at $24.87 on Friday. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 80.23 and a beta of 2.25. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.76 and a quick ratio of 1.34. BrightSpring Health Services has a 1 year low of $11.96 and a 1 year high of $25.57. The firm has a 50-day moving average of $21.54 and a two-hundred day moving average of $20.51.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.03. The company had revenue of $3.15 billion during the quarter, compared to analysts' expectations of $2.99 billion. BrightSpring Health Services had a net margin of 0.55% and a return on equity of 9.29%. The firm's quarterly revenue was up 15.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.10 EPS. BrightSpring Health Services has set its FY 2025 guidance at EPS. On average, research analysts forecast that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Insider Activity at BrightSpring Health Services

In other BrightSpring Health Services news, major shareholder Phoenix Aggregator L.P. Kkr sold 13,288,101 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.15, for a total transaction of $281,043,336.15. Following the transaction, the insider owned 79,671,883 shares in the company, valued at approximately $1,685,060,325.45. This represents a 14.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jon B. Rousseau sold 531,840 shares of the company's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total transaction of $11,567,520.00. Following the transaction, the insider owned 1,184,133 shares in the company, valued at $25,754,892.75. The trade was a 30.99% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,919,941 shares of company stock valued at $337,025,856. 3.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of BTSG. Wells Fargo & Company MN increased its stake in BrightSpring Health Services by 38.7% during the 4th quarter. Wells Fargo & Company MN now owns 63,155 shares of the company's stock valued at $1,076,000 after purchasing an additional 17,617 shares in the last quarter. Envestnet Asset Management Inc. acquired a new stake in shares of BrightSpring Health Services in the fourth quarter worth $188,000. Legal & General Group Plc increased its stake in shares of BrightSpring Health Services by 4.8% in the fourth quarter. Legal & General Group Plc now owns 64,631 shares of the company's stock worth $1,101,000 after acquiring an additional 2,945 shares during the period. First Trust Advisors LP acquired a new stake in shares of BrightSpring Health Services in the fourth quarter worth $987,000. Finally, MetLife Investment Management LLC increased its stake in shares of BrightSpring Health Services by 4.9% in the fourth quarter. MetLife Investment Management LLC now owns 33,117 shares of the company's stock worth $564,000 after acquiring an additional 1,548 shares during the period.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.